These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 4742499)
1. Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037). DeConti RC; Hubbard SP; Pinch P; Bertino JR Cancer Chemother Rep; 1973 Apr; 57(2):201-7. PubMed ID: 4742499 [No Abstract] [Full Text] [Related]
2. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer. Perloff M; Muggia FM; Ackerman C Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718 [No Abstract] [Full Text] [Related]
3. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH; Livingston RB; Gottlieb JA Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related]
4. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study. Firat D; Tekuzman G Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843 [No Abstract] [Full Text] [Related]
5. Nitrosoureas: a reappraisal of clinical trials. Katz ME; Glick JH Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866 [TBL] [Abstract][Full Text] [Related]
6. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms. Gailani S; Kutcher J J Med; 1973; 4(4):209-18. PubMed ID: 4520348 [No Abstract] [Full Text] [Related]
7. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. Rosenblum ML; Reynolds AF; Smith KA; Rumack BH; Walker MD J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763 [No Abstract] [Full Text] [Related]
8. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. Klaassen DJ; Rapp E Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046 [No Abstract] [Full Text] [Related]
16. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4]. Brunner KW; Maurice P; Sonntag RW Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016 [No Abstract] [Full Text] [Related]
17. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer. Rossi A; Riva A; Bonadonna G Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958 [No Abstract] [Full Text] [Related]
18. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma. Lokich JJ; Skarin AT Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058 [No Abstract] [Full Text] [Related]
19. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144 [No Abstract] [Full Text] [Related]
20. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study. Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783 [No Abstract] [Full Text] [Related] [Next] [New Search]